Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction
- 1 September 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 64 (8), 448-453
- https://doi.org/10.1016/0002-9149(89)90419-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarctionThe American Journal of Cardiology, 1988
- Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Urokinase in Acute Myocardial Infarction: Results of the German Activator Urokinase Study (GAUS)Journal of the American College of Cardiology, 1988
- Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1987
- Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarctionThe American Journal of Cardiology, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.Circulation, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Statistical estimations in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1974
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957